Bridging the immunity gap: improving animal welfare without antibiotics February 21, 2024 · V-Bio Ventures
Fund+ Portfolio Company Tubulis Closes Upsized EUR 128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline Financing round co-led by EQT Life Sciences and Nextech Invest1, with participation from current and new leading global biotechnology investors […] March 14, 2024 · Press Release
Azalea Vision Secures Prestigious European Innovation Council (EIC) Transition Grant Innovative Smart Contact Lens Developer Awarded €2.5M in Funding for Groundbreaking Ocular Health Technology Ghent, Belgium, March 12th, 2024 – […] March 12, 2024 · Press Release
Optimizing the patient care pathway through data-driven insights The patient’s journey in a healthcare setting is influenced by factors beyond the mere medical aspects of the case. Local […] February 20, 2024 · Janssen Pharmaceutica
Nutritional labels “in the wild”: how they affect your snack choice Barely any people stick to a three-meals-a-day plan. Snacking is part of our culture and can even contribute to a […] February 16, 2024 · BioVox
Beyond gluten-free: a hopeful future for those who suffer from Celiac disease Gluten-free dietary products contain more sugar and fats but fewer nutrients and are generally more expensive. A gluten-free diet can […] February 14, 2024 · SciMingo
Looking forward: Azalea Vision's smart lens is a game-changer for ocular disorders January 24, 2024 · BioVox
V-Bio Ventures portfolio company Protealis secures EUR 22 million in oversubscribed B round funding to propel sustainable plant protein seed solutions Ghent, 23 January 2024 – Protealis, a leading innovator in seed solutions for sustainable plant proteins based in Ghent, Belgium, […] January 23, 2024 · V-Bio Ventures
QbD Chair for Precision Oncology Research in Glioblastoma extended for three years The QbD Chair supports the research of Professor Frederik De Smet on glioblastoma, an aggressive form of brain cancer. Behind […] January 22, 2024 · Press Release
How the Chair of the Board can empower a first-time biotech CEO January 19, 2024 · V-Bio Ventures
Smart cities as living laboratories: a data-driven strategy for creating a sustainable future Similar to the growing use of large-scale scientific data to guide laboratory research, urban data presents significant potential for informed […] January 19, 2024 · BioVox
V-Bio Ventures-funded Tanai Therapeutics develops first-in-class therapeutics for obesity Ghent, 6 December 2023 – VIB, Flanders’ leading life sciences institute, together with lead investor V-Bio Ventures has launched a […] December 6, 2023 · V-Bio Ventures
Obulytix is developing a revolutionary solution for antibiotic resistance Obulytix, a spin-off based on research results from Ghent University and KU Leuven, has built a platform that creates new ways to tackle bacterial infections. December 5, 2023 · Press Release
Azalea Vision announces first on-eye test of ALMA, its revolutionary smart contact lens Promises New Hope for Patients with Vision Disorders Ghent, Belgium (December 4th, 2023) In a significant milestone, Azalea Vision, […] December 4, 2023 · Press Release